IRS - Sygehus Lillebælt, Forskningsenhed for Klinisk Mikrobiologi (Vejle)

Medicin og biovidenskab

1. Denmark 100%
2. Streptococcus agalactiae 76%
3. Lyme Neuroborreliosis 59%
4. Polymerase Chain Reaction 37%
5. Cohort Studies 34%
6. Infections 33%
7. Urinary Tract Infections 24%
8. Bacteremia 24%
9. Urine 21%
10. Incidence 20%
11. SARS Virus 19%
12. Blood Culture 19%
13. Cross Infection 18%
14. Meningitis 18%
15. Anti-Bacterial Agents 17%
16. Chlamydia trachomatis 16%
17. Cerebrospinal Fluid 16%
18. Echinocandins 16%
19. Genome 15%
20. Microbiology 15%
21. Borrelia burgdorferi Group 14%
22. Methicillin-Resistant Staphylococcus aureus 14%
23. Central Venous Catheters 14%
24. Population 14%
25. Bacteriuria 13%
26. Pregnancy 13%
27. Candida glabrata 13%
28. taurolidine 12%
29. Databases 12%
30. Disease Outbreaks 12%
31. Pregnant Women 11%
32. Nucleic Acid Amplification Techniques 11%
33. Whole Genome Sequencing 11%
34. Registries 11%
35. Anaerobic Bacteria 11%
36. Bacteria 11%
37. Confidence Intervals 10%
38. Prospective Studies 10%
39. General Practice 10%
40. Catheter-Related Infections 10%
41. Enterococcus faecium 10%
42. Fungemia 10%
43. Child 10%
44. Mortality 10%
45. Antibiotic Prophylaxis 10%
46. Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry 10%
47. Borrelia burgdorferi 10%
48. Candidemia 9%
49. Parturition 9%
50. Streptococcus 9%
51. Antibodies 9%
52. Escherichia coli 9%
53. Hand 9%
54. Central Nervous System Infections 9%
55. Observational Studies 9%
56. Clone Cells 8%
57. Endocarditis 8%
58. Candida albicans 8%
59. carbapenemase 8%
60. Azoles 8%
61. Alcohols 8%
62. Klebsiella pneumoniae 8%
63. Influenza A virus 7%
64. Staphylococcus aureus 7%
65. Borrelia 7%
66. Candida 7%
67. Serum Albumin 7%
68. Catheters 7%
69. Sensitivity and Specificity 7%
70. Lasers 7%
71. Technology 7%
72. Viral Load 6%
73. Antigens 6%
74. Cesarean Section 6%
75. Neisseria meningitidis 6%
76. Rat-Bite Fever 6%
77. Survival 6%
78. Hospital Emergency Service 6%
79. Heparin 6%
80. Therapeutics 6%
81. Hand Hygiene 6%
82. Plasmodium cynomolgi 6%
83. homocysteine-thiolactone-nicotinamide 6%
84. C-Reactive Protein 6%
85. Risk Assessment 6%
86. Genes 6%
87. rRNA Genes 6%
88. Testicular Microlithiasis 6%
89. Complement C3d 6%
90. Streptococcus pneumoniae 6%
91. Streptococcus mitis 6%
92. Delivery of Health Care 6%
93. Vaccines 6%
94. Interleukin-6 6%
95. Serum 5%
96. Serogroup 5%
97. Tazobactam Drug Combination Piperacillin 5%
98. 23S Ribosomal RNA 5%
99. Streptococcus oralis 5%
100. Lyme Disease 5%